Description
TB500 & BPC-157 Blend 10mg: Research-Grade Peptide for Laboratory Studies
The TB500 & BPC-157 Blend 10mg is a high-purity, research-grade peptide combination formulated specifically for controlled laboratory studies. This product is intended strictly for scientific research and is not approved for human consumption, clinical use, or veterinary applications.
What is TB500?
TB500, also known as Thymosin Beta-4, is a synthetic peptide analog of a naturally occurring peptide in the body. It is commonly used in laboratory research to study tissue processes, cellular activity, and molecular pathways associated with tissue regeneration and repair.
-
Laboratory Applications: TB500 is used in vitro and in vivo in controlled research models to explore cellular and molecular mechanisms.
-
Experimental Models: Supports research on soft tissue, tendons, and cellular pathways related to tissue maintenance.
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a naturally occurring human gastric protein. It is primarily used in laboratory settings to investigate cellular processes, tissue interactions, and molecular mechanisms in controlled experimental models.
-
Research Applications: Suitable for in vitro, ex vivo, and other experimental models studying tissue-related cellular pathways.
-
Peptide Studies: Used in laboratory protocols focusing on peptide interactions at the cellular and molecular level.
Key Research Applications of the TB500 & BPC-157 Blend
-
Molecular and Cellular Research: Designed for studies exploring peptide interactions and signaling pathways in controlled laboratory settings.
-
Controlled Experimental Protocols: Compatible with single-dose, multi-dose, and long-term laboratory experiments.
-
Peptide Dynamics: Enables research into combined peptide effects in cellular and molecular studies.
-
Laboratory-Grade Research Tool: Formulated to provide consistent and reproducible results under research conditions.
Why Choose the TB500 & BPC-157 Blend 10mg?
This 10mg peptide blend is produced under strict laboratory-grade quality standards for reproducibility and experimental precision.
-
High-Purity Formulation: Manufactured and tested to meet rigorous research standards.
-
Flexible Laboratory Use: Suitable for a variety of experimental designs exploring peptide behavior and molecular interactions.
-
Research-Only Use: Not intended for human, clinical, or veterinary consumption.
Quality Assurance & Purity Testing Guarantee
We provide a purity testing guarantee for all batches of the TB500 & BPC-157 Blend 10mg. Researchers are encouraged to verify the peptides’ purity through third-party accredited laboratories. If results do not meet stated standards, a full refund and reimbursement of testing costs will be provided.
COA: 3P Tested Purity Results: BPC-157 | 99.258% | 11.3 mg | View Test
COA: 3P Tested Purity Results: TB500 | 99.165% | 10.84 mg | View Test
Important Legal Disclaimer
For Research Purposes Only
The TB500 & BPC-157 Blend 10mg is strictly intended for laboratory and scientific research. This product is not for human consumption, clinical use, or veterinary applications and is not approved by the FDA, Health Canada, or any other regulatory authority for therapeutic use. By purchasing, you confirm that this product will be used exclusively in compliance with applicable research laws and regulations.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Bock-Marquette I, et al. Nature. 2004;432(7016):466-472. In embryonic mouse cardiomyocyte and endothelial culture and a mouse coronary artery ligation model, measured cell migration, myocyte survival and ILK/Akt kinase activity. Source · PMID 15565145
- Malinda KM, et al. FASEB J. 1997;11(6):474-481. In human umbilical vein endothelial cell (HUVEC) culture, measured directional chemotactic migration in Boyden-chamber assays. Source · PMID 9194528
- Philp D, et al. FASEB J. 2003;17(14):2103-2105. In HUVEC culture and chick aortic arch explants, measured migration, adhesion and vessel sprouting elicited by the LKKTETQ actin-binding motif at approximately 50 nM. Source · PMID 14500546
- Chang CH, et al. J Appl Physiol. 2011;110(3):774-780. In rat Achilles tendon explant culture and isolated tendon fibroblasts, measured explant outgrowth, fibroblast survival under oxidative stress, migration, and FAK/paxillin phosphorylation. Source · PMID 21030672
- Hsieh MJ, et al. J Mol Med (Berl). 2017;95(3):323-333. In chick chorioallantoic membrane assay, a rat hind-limb ischaemia model and human endothelial cell culture, measured vessel density, endothelial tube formation and VEGFR2-Akt-eNOS phosphorylation. Source · PMID 27847966
- Chang CH, et al. Molecules. 2014;19(11):19066-19077. In primary tendon fibroblasts from Sprague-Dawley rat Achilles tendon, measured growth hormone receptor mRNA and protein levels, PCNA expression and JAK2 phosphorylation. Source · PMID 25415472
Literature notes: Published work concerns full-length thymosin beta-4 or its LKKTETQ actin-binding fragment. Equivalence between those and material marketed as TB-500 is not established in the literature. The published base for this compound is small and concentrated in a limited number of research groups, with little independent replication of in vivo findings.
Related Research Compounds
Browse more compounds in Regenerative Peptides, or view the full research peptide catalogue.
